MeiraGTx Announces the Acquisition of Botaretigene Sparoparvovec (bota-vec) for the Treatment of X-linked Retinitis Pigmentosa (XLRP)GlobeNewsWire • 04/16/26
MeiraGTx Announces Positive Three-year Data from the Phase 1 AQUAx Clinical Study of AAV-hAQP1 for the Treatment of Grade 2/3 Late Radiation-Induced XerostomiaGlobeNewsWire • 04/16/26
MeiraGTx to Present 3-Year Data from the Phase 1 AQUAx Clinical Study of AAV-hAQP1 for the Treatment of Grade 2/3 Radiation-Induced Xerostomia on Thursday, April 16, 2026GlobeNewsWire • 04/14/26
Strength Seen in MeiraGTx (MGTX): Can Its 6.2% Jump Turn into More Strength?Zacks Investment Research • 03/31/26
MeiraGTx Holdings plc (MGTX) Presents at RBC Capital Markets Virtual Ophthalmology Conference TranscriptSeeking Alpha • 03/27/26
MeiraGTx Holdings PLC (MGTX) Q4 Earnings and Revenues Surpass EstimatesZacks Investment Research • 03/26/26
MeiraGTx Announces FDA Breakthrough Therapy Designation for AAV2-hAQP1 for the Treatment of Grade 2 and Grade 3 Radiation-Induced Xerostomia (RIX) and Reports Fourth Quarter and Full Year 2025 Financial and Operational ResultsGlobeNewsWire • 03/26/26
ZipBio and MeiraGTx Enter into Exclusive License Agreement to Advance First-in-Class AAV Gene Therapy for Geographic AtrophyPRNewsWire • 02/03/26
Graviton Bioscience to Present Selective ROCK2 Obesity Data at 8th Annual Evercore HealthCONx ConferencePRNewsWire • 11/20/25
MeiraGTx Holdings PLC (MGTX) Reports Q3 Loss, Lags Revenue EstimatesZacks Investment Research • 11/13/25
MeiraGTx: Latest Eli Lilly Partnership Ignites Riboswitch Technology PotentialSeeking Alpha • 11/12/25
MeiraGTx Enters into Strategic Collaboration with Eli Lilly and Company to Develop and Commercialize Genetic Medicines in OphthalmologyGlobeNewsWire • 11/10/25
MeiraGTx Holdings PLC (MGTX) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 ReleaseZacks Investment Research • 11/05/25
MeiraGTx Announces Two Posters at the European Society of Gene and Cell Therapy (ESGCT) 2025 Annual CongressGlobeNewsWire • 10/07/25
MeiraGTx Holdings PLC (MGTX) Reports Q2 Loss, Beats Revenue EstimatesZacks Investment Research • 08/14/25
MeiraGTx Announces the Presentation of Four Posters at the American Society of Gene and Cell Therapy (ASGCT) 2025 Annual MeetingGlobeNewsWire • 05/13/25
MeiraGTx Holdings PLC (MGTX) Reports Q1 Loss, Misses Revenue EstimatesZacks Investment Research • 05/13/25